Achieving herd immunity in South America.

dc.contributor.author

Lucero-Prisno, Don Eliseo

dc.contributor.author

Shomuyiwa, Deborah Oluwaseun

dc.contributor.author

Vicente, Creuza Rachel

dc.contributor.author

Méndez, María José González

dc.contributor.author

Qaderi, Shohra

dc.contributor.author

Lopez, Jaifred Christian

dc.contributor.author

Mogessie, Yidnekachew Girma

dc.contributor.author

Alacapa, Jason

dc.contributor.author

Chamlagai, Lila

dc.contributor.author

Ndayizeye, Remy

dc.contributor.author

Kinay, Pelin

dc.date.accessioned

2024-04-26T17:49:04Z

dc.date.available

2024-04-26T17:49:04Z

dc.date.issued

2023-02

dc.description.abstract

South America, once an epicenter of COVID-19, has stayed on the road of continued management of the pandemic. The region initially struggled to cope with the pandemic as it experienced spiraling numbers of infections and overwhelmed public health systems. South America has risen in its pandemic response to be the region with the highest global vaccination rate. The region posed a strong vaccination drive, with over 76% of its population fully vaccinated with the initial protocol. South America leveraged its deeply rooted vaccination culture and public health confidence among its population. Herd immunity is an integral concept in population infectious disease management. Attaining herd immunity is presently not feasible with available vaccines, but the high vaccination rate in the region depicts the acceptance of vaccination as a strategy for population protection. The availability of effective transmission-blocking vaccines, the continuous implementation of strategies that will enable the undisrupted supply of the vaccines, equity in access to the vaccines, improved vaccine acceptance, and trust in the vaccination and public health systems will help shepherd the region towards herd immunity. Local vaccine production backed with investment in infrastructure and international collaboration for research and knowledge development will also drive population safety.

dc.identifier

10.1186/s41256-023-00286-2

dc.identifier.issn

2397-0642

dc.identifier.issn

2397-0642

dc.identifier.uri

https://hdl.handle.net/10161/30579

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Global health research and policy

dc.relation.isversionof

10.1186/s41256-023-00286-2

dc.rights.uri

https://creativecommons.org/licenses/by-nc/4.0

dc.subject

Humans

dc.subject

Vaccines

dc.subject

Vaccination

dc.subject

Immunity, Herd

dc.subject

South America

dc.subject

COVID-19

dc.title

Achieving herd immunity in South America.

dc.type

Journal article

duke.contributor.orcid

Lopez, Jaifred Christian|0000-0002-8273-992X

pubs.begin-page

2

pubs.issue

1

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Student

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Population Health Sciences

pubs.publication-status

Published

pubs.volume

8

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Achieving herd immunity in South America.pdf
Size:
1.2 MB
Format:
Adobe Portable Document Format